SSC Shutdown

The Scientist, Nov. 29, 1993, page 12) apparently feels that anyone who didn't support the superconducting supercollider (SSC) lacked the "reasonable science savvy" to "vote correctly" on the matter. This sounds like the tired old argument: "You must not understand the issue or you would agree with me." No one is going to argue that the knowledge the SSC could provide is not worth obtaining. But just because something is worth doing

Written byStephen Christensen
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

No one is going to argue that the knowledge the SSC could provide is not worth obtaining. But just because something is worth doing does not mean that it is worth doing at any cost. Why isn't it reasonable to consider what could be done with those billions of public dolars? Yes, it would be nice to support particle physics, but what about cancer research, or the fight against crime? Just because I apply a cost-benefit analysis to the question of how to spend our limited tax dollars and come up with a different answer from Lederman's should not brand me as scientifically illiterate. Perhaps the fact that he feels it does shows that it may be the scientists who are out of touch--not the politicians.

STEPHEN B. CHRISTENSEN
Dow North America
Midland, Mich. 48667

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies